Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,853.35 -1,165.23 (-1.79%) CMC Crypto 200
1,383.71 -12.82 (-0.92%)
ASLAN Pharmaceuticals Limited (ASLN)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 10.14M |
| Enterprise value | 15.71M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.61 |
| Price/book (mrq) | 2.14 |
| Enterprise value/revenue | 1.31 |
| Enterprise value/EBITDA | -0.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.47 |
| 52-week change 3 | -89.20% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 4.6900 |
| 52-week low 3 | 0.3920 |
| 50-day moving average 3 | 0.6016 |
| 200-day moving average 3 | 1.1700 |
Share statistics
| Avg vol (3-month) 3 | 1.23M |
| Avg vol (10-day) 3 | 1.52M |
| Shares outstanding 5 | 22.63M |
| Implied shares outstanding 6 | 24.38M |
| Float 8 | 488.15M |
| % held by insiders 1 | 0.05% |
| % held by institutions 1 | 15.48% |
| Shares short (15 Apr 2024) 4 | 250.19k |
| Short ratio (15 Apr 2024) 4 | 0.56 |
| Short % of float (15 Apr 2024) 4 | 1.12% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.11% |
| Shares short (prior month 15 Mar 2024) 4 | 290.51k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 13 Mar 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -364.46% |
Management effectiveness
| Return on assets (ttm) | -63.71% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 12M |
| Revenue per share (ttm) | 0.73 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -43.71M |
| Net income avi to common (ttm) | -44.22M |
| Diluted EPS (ttm) | -2.7500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 21.25M |
| Total cash per share (mrq) | 0.04 |
| Total debt (mrq) | 26.83M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.84 |
| Book value per share (mrq) | -0.75 |
Cash flow statement
| Operating cash flow (ttm) | -46.64M |
| Levered free cash flow (ttm) | -30.01M |
© 2024 Yahoo. All rights reserved.